The global drug and gene delivery devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and growing demand for minimally invasive procedures. The oral segment accounted for the largest share in the global drug and gene delivery devices market in 2018. Oral segment is expected to maintain its dominance throughout the forecast period due to its ease of use and convenience.
- The growing number of aging population coupled with rising incidence rates of chronic diseases are also expected to fuel the growth in this market over the next few years.
- In addition, technological advancements in drug and gene delivery devices are also expected to drive their adoption across various therapeutic areas including oncology, cardiology, neurology and others over the forecast period (2016-2020). For instance, recent developments in nanotechnology have led to improved efficacy and safety profiles for these products which has increased their adoption rates among patients suffering from various conditions such as cancer or diabetes mellitus type 2 (DM2).
Industry Growth Insights published a new data on “Drug And Gene Delivery Devices Market”. The research report is titled “Drug And Gene Delivery Devices Market research by Types (Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical), By Applications (Hospital, Laboratory), By Players/Companies Pfizer, F. Hoffmann-La Roche, Johnson and Johnson, Novartis, Bayer, Becton, Dickinson, Uniqure, SiBiono Gene, Epeius Biotechnologies, Shanghai Sunway Biotech, Human Stem Cells”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug And Gene Delivery Devices Market Research Report
By Type
Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
By Application
Hospital, Laboratory
By Companies
Pfizer, F. Hoffmann-La Roche, Johnson and Johnson, Novartis, Bayer, Becton, Dickinson, Uniqure, SiBiono Gene, Epeius Biotechnologies, Shanghai Sunway Biotech, Human Stem Cells
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Drug And Gene Delivery Devices Market Report Segments:
The global Drug And Gene Delivery Devices market is segmented on the basis of:
Types
Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- F. Hoffmann-La Roche
- Johnson and Johnson
- Novartis
- Bayer
- Becton
- Dickinson
- Uniqure
- SiBiono Gene
- Epeius Biotechnologies
- Shanghai Sunway Biotech
- Human Stem Cells
Highlights of The Drug And Gene Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Inhalation
- Transdermal
- Injectable
- Ocular
- Nasal
- Topical
- By Application:
- Hospital
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug And Gene Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug and gene delivery devices are medical devices that help to administer drugs or genes to patients. These devices can be inserted into the body through a vein, used as an injection, or implanted under the skin. They can also be used in conjunction with other medical treatments, such as chemotherapy or radiation therapy.
Some of the key players operating in the drug and gene delivery devices market are Pfizer, F. Hoffmann-La Roche, Johnson and Johnson, Novartis, Bayer, Becton, Dickinson, Uniqure, SiBiono Gene, Epeius Biotechnologies, Shanghai Sunway Biotech, Human Stem Cells.
The drug and gene delivery devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug And Gene Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug And Gene Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug And Gene Delivery Devices Market - Supply Chain
4.5. Global Drug And Gene Delivery Devices Market Forecast
4.5.1. Drug And Gene Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug And Gene Delivery Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug And Gene Delivery Devices Market Absolute $ Opportunity
5. Global Drug And Gene Delivery Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Inhalation
5.3.3. Transdermal
5.3.4. Injectable
5.3.5. Ocular
5.3.6. Nasal
5.3.7. Topical
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug And Gene Delivery Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Laboratory
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug And Gene Delivery Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug And Gene Delivery Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug And Gene Delivery Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug And Gene Delivery Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug And Gene Delivery Devices Demand Share Forecast, 2019-2026
9. North America Drug And Gene Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug And Gene Delivery Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Laboratory
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Inhalation
9.7.3. Transdermal
9.7.4. Injectable
9.7.5. Ocular
9.7.6. Nasal
9.7.7. Topical
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug And Gene Delivery Devices Demand Share Forecast, 2019-2026
10. Latin America Drug And Gene Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug And Gene Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Laboratory
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Inhalation
10.7.3. Transdermal
10.7.4. Injectable
10.7.5. Ocular
10.7.6. Nasal
10.7.7. Topical
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug And Gene Delivery Devices Demand Share Forecast, 2019-2026
11. Europe Drug And Gene Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug And Gene Delivery Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Laboratory
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Inhalation
11.7.3. Transdermal
11.7.4. Injectable
11.7.5. Ocular
1.7.6. Nasal
11.7.7. Topical
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug And Gene Delivery Devices Demand Share, 2019-2026
12. Asia Pacific Drug And Gene Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug And Gene Delivery Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Laboratory
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Inhalation
12.7.3. Transdermal
12.7.4. Injectable
12.7.5. Ocular
12.7.6. Nasal
12.7.7. Topical
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug And Gene Delivery Devices Demand Share, 2019-2026
13. Middle East & Africa Drug And Gene Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug And Gene Delivery Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug And Gene Delivery Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Laboratory
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug And Gene Delivery Devices Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Inhalation
13.7.3. Transdermal
13.7.4. Injectable
13.7.5. Ocular
13.7.6. Nasal
13.7.7. Topical
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug And Gene Delivery Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug And Gene Delivery Devices Market: Market Share Analysis
14.2. Drug And Gene Delivery Devices Distributors and Customers
14.3. Drug And Gene Delivery Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pfizer
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. F. Hoffmann-La Roche
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson and Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Becton
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dickinson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Uniqure
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SiBiono Gene
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Epeius Biotechnologies
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Shanghai Sunway Biotech
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Human Stem Cells
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook